Monash retains world-leading rank for pharmacy education


Monash Parkville campus. Source: Supplied.

It sits in good company alongside the University of Oxford and Harvard University

Melbourne’s Monash University has retained its number two ranking in the world for Pharmacy and Pharmacology, according to the 2021 QS World University Rankings by Subject released on Thursday.

The University of Oxford in the UK claimed the number one spot while Harvard University in the United States was ranked after Monash at number three, out of 856 universities considered in this subject.

Since the subject rankings were introduced in 2011, Monash University has been consistently ranked in the most elite group of Pharmacy and Pharmacology programs worldwide, with an average top 10 ranking.

Its second spot ranking means it retains its long-held position as Australia’s and the Asia-Pacific’s number one University for Pharmacy and Pharmacology.

“To rank number two in the world for Pharmacy and Pharmacology for the second year in a row reflects the Faculty’s continuous drive to be at the forefront of pharmaceutical research, practice and education on the world stage,” said Professor Arthur Christopoulos, Dean of the Faculty of Pharmacy and Pharmaceutical Sciences.

“As the experts in medicines and the way they interact with the body, pharmacists and pharmaceutical scientists play a vital role in our healthcare system.

“Now, more than ever, the world needs these skill sets as we collectively tackle a number of global health challenges,” said Professor Christopoulos.

“The Faculty’s success would not be possible without the dedication of our talented staff and students and the generosity of our collaborators in the pharmacy profession and in biomedical research and education.”

The next Australian university on the list is the University of Sydney, ranked at number 13 for Pharmacy & Pharmacology followed by the University of Queensland at number 31.

The QS World University Rankings are compiled from an analysis of more than 13.9 million unique papers and global surveys by employers and academics.

Previous Priceline faces ‘imminent’ class action from angry franchisees
Next RCTs show small or no effect on mortality, hospital admission

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.